Think a trip to the pharmacy is overwhelming? Try this: One million billion billion billion billion billion billion. That’s a 1 with 60 zeroes after it. That’s the number of potential new medicines that could still be made, according to a new study. It may be more than the number of stars in the universe.
Big news on the pharma front today: for the first time the U.S. Federal Drug Administration has approved a drug for humans that was produced in a genetically engineered plant cell. The approval could open the door to a range of biologic drugs that are generated in plant cells and then transferred to human patients.
In the future, implantable computerized dispensaries will replace trips to the pharmacy or doctor’s office, automatically leaching drugs into the blood from medical devices embedded in our bodies. These small wireless chips promise to reduce pain and inconvenience, and they’ll ensure that patients get exactly the amount of drugs they need, all at the push of a button.
A team at the University of Texas has created a fat-burning drug that doesn't so much burn fat as it seeks and destroys it. Instead of suppressing appetite or increasing metabolism, this drug systematically destroys the blood supply to fat tissue--and in a recent study, obese rhesus monkeys lost 11 percent of their body weight when treated with the drug.
A new database developed by Spanish biologists is giving pharmaceutical quick access to protein structure data that could lead to more rapid development of important biologic drugs. The database, known as MoDEL, contains protein motion data for more than 1,700 different human proteins, making it the largest such database of proteins in the world.